Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China flag China · Delayed Price · Currency is CNY
29.94
+1.97 (7.04%)
Apr 29, 2026, 3:00 PM CST

SHA:688319 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
246.61224.16362.07269.23254.37
Upgrade
Trading Asset Securities
2.617.5090200
Upgrade
Cash & Short-Term Investments
249.21241.66362.07359.23454.37
Upgrade
Cash Growth
3.12%-33.26%0.79%-20.94%298.63%
Upgrade
Accounts Receivable
655.97570.35491.55491.69342.52
Upgrade
Other Receivables
2.5811.13.781.1
Upgrade
Receivables
658.55571.35492.65495.48343.62
Upgrade
Inventory
62.3885.6872.1278.5274.5
Upgrade
Prepaid Expenses
1.05-000.06
Upgrade
Other Current Assets
25.149.454.352.662.42
Upgrade
Total Current Assets
996.33908.14931.19935.89874.98
Upgrade
Property, Plant & Equipment
630.67572.3425.87378.35259.27
Upgrade
Other Intangible Assets
16.916.3316.8217.5113.78
Upgrade
Long-Term Deferred Tax Assets
24.9118.2114.079.567.11
Upgrade
Long-Term Deferred Charges
354.04291.5195.76132.3134.93
Upgrade
Other Long-Term Assets
0.220.5628.895.2421.82
Upgrade
Total Assets
2,0231,8071,6131,4791,212
Upgrade
Accounts Payable
153.0786.2940.0680.6834.28
Upgrade
Accrued Expenses
465.14368.06346.13321.65251.98
Upgrade
Short-Term Debt
3024.224.28535
Upgrade
Current Portion of Long-Term Debt
68.8287.4231.6910-
Upgrade
Current Portion of Leases
3.24----
Upgrade
Current Income Taxes Payable
-9.443.749.464.03
Upgrade
Current Unearned Revenue
0.990.513.626.717.5
Upgrade
Other Current Liabilities
15.8319.6726.7911.738.88
Upgrade
Total Current Liabilities
737.07595.59476.22525.23341.66
Upgrade
Long-Term Debt
323.72249.53177.2929.99-
Upgrade
Long-Term Leases
7.260.644.439.043.25
Upgrade
Long-Term Unearned Revenue
29.1624.7919.9820.1118.67
Upgrade
Long-Term Deferred Tax Liabilities
8.392.462.722.562.3
Upgrade
Other Long-Term Liabilities
13.480.531.210.091.33
Upgrade
Total Liabilities
1,119873.54681.84587.02367.22
Upgrade
Common Stock
405.71405.93406.16405.27405.27
Upgrade
Additional Paid-In Capital
560.58606605.75580.95570.56
Upgrade
Retained Earnings
-59.44-81.7-87.04-104.59-131.17
Upgrade
Treasury Stock
-3.17-5.56-7.96--
Upgrade
Total Common Equity
903.68924.68916.91881.63844.66
Upgrade
Minority Interest
0.38.8213.8610.22-
Upgrade
Shareholders' Equity
903.98933.5930.77891.85844.66
Upgrade
Total Liabilities & Equity
2,0231,8071,6131,4791,212
Upgrade
Total Debt
433.03361.79237.61134.0338.25
Upgrade
Net Cash (Debt)
-183.82-120.13124.47225.2416.11
Upgrade
Net Cash Growth
---44.73%-45.88%381.08%
Upgrade
Net Cash Per Share
-0.45-0.300.310.561.08
Upgrade
Filing Date Shares Outstanding
405.71405.93406.16405.27405.27
Upgrade
Total Common Shares Outstanding
405.71405.93406.16405.27405.27
Upgrade
Working Capital
259.26312.55454.97410.67533.31
Upgrade
Book Value Per Share
2.232.282.262.182.08
Upgrade
Tangible Book Value
886.78908.35900.08864.11830.88
Upgrade
Tangible Book Value Per Share
2.192.242.222.132.05
Upgrade
Buildings
224.69224.6996.22103.17103.17
Upgrade
Machinery
383.4318.26299.39261.88245.29
Upgrade
Construction In Progress
226.26211.27181.35135.4911.63
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.